Spanning anterior to posterior disease models, Ichor Life Sciences is an established ophthalmic cro providing preclinical research services to support the development of innovative ophthalmic therapies. With over 10 years of experience in space, we have seen and supported some of the most diverse models. Let our scientific staff assist you with developing your investigational product today!
Featured Capabilities
Our ophthalmic cro research team utilizes industry-best equipment to conduct studies. Quality equipment for quality results.
- Retinal scans using spectral-domain optical coherence tomography
- Track retinal disease progression using superior image quality with SD-OCT. More accurate measurements means clearer characterization of pathogenesis in our disease models.
- High-definition fundoscopy with automated image quantification
- Obtain high definition images in anterior and posterior segment disease models to better inform pathogenesis and therapeutic response. Our automated scoring algorithms provide robust, quantitative read-outs.
- Advanced intraocular drug delivery capabilities
- Microinfusion pumps and micromanipulator devices for rodents provide accurate, efficient, and proficient drug delivery. Available administration modalities include intravitreal, subretinal, intracameral, suprachoroidal, and topical.
- Complex dissections, bioanalysis, and histopathology capabilities
- We perform complex dissection for all ocular tissues. From flat-mounts to whole eye collections, we provide H&E, IHC, and IF processing, flow cytometry, ELISA, western-blot, and mass spectrometry.
- Advanced retinal function testing with electroretinography
- Evaluate the preservation or restoration of ocular function with high quality ERGs. This powerful technique tests retinal function in response to electrical impulses.
- High-definition fluorescein angiography
- We provide clear and consistent fluorescent angiograms and fundus autofluorescence measurements for a variety of different ocular models. Quantitation using automated scoring is also available.
- Industry leading intraocular pressure measurements
- IOP measurements can be compromised by external effects, leading to false readings. Our positive reinforcement training (PRT) ensures study animals are stress free to provide reliability and consistency in our measurements.
Your Results Await
This featured Stargardt disease research model utilizes the ABCA4-/- transgenic knockout mouse for testing gene therapy and other investigational products for Stargardt disease and dry age-related macular degeneration. Blue light illumination in the ABCA4-/- strain activates reactive lipofuscin fluorophores and induces retinal lesions, which can be measured by fundus imaging, OCT, and histology. Functional impairment by ERG is also observed. This model is ideal for interventions aimed at directly or indirectly reducing lipofuscin burden or cytoprotective interventions intended to preserve RPE and photoreceptor structure and function.
Endpoints with Goals in Mind
Advanced Imaging in CNV Model
We are an ophthalmic cro that utilizes state-of-the-art imaging modalities to provide the most robust data sets in support of client projects. If a picture is worth 1,000 words our data speaks volumes.
Histology for Target Engagement
We do not stop just at efficacy endpoints. Confirmation of target engagement and a clear understanding of mechanism of action inform downstream product development.
Capabilities and Services Summary
Frequently Asked Questions
Answers to some of the most common questions about our ophthalmic cro service offerings.



